Parametric Portfolio Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$4.32M Buy
47,691
+11,877
+33% +$972K ﹤0.01% 1953
2021
Q4
$3.27M Buy
35,814
+4,682
+15% +$401K ﹤0.01% 2139
2021
Q3
$2.52M Buy
31,132
+953
+3% +$80.1K ﹤0.01% 2308
2021
Q2
$2.81M Buy
30,179
+12,647
+72% +$1.23M ﹤0.01% 2236
2021
Q1
$1.88M Buy
17,532
+15,124
+628% +$1.57M ﹤0.01% 2818
2020
Q4
$210K Sell
2,408
-11,527
-83% -$814K ﹤0.01% 3753
2020
Q3
$962K Buy
+13,935
New +$896K ﹤0.01% 2944

Other funds holding NARI

Parametric Portfolio Associates's NARI Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Inari Medical, Inc. Common Stock (NARI) stake by 33% in Q1 2022, buying an estimated $972K and bringing the position to 47,691 shares worth $4.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

Parametric Portfolio Associates first reported a position in NARI in Q3 2020 and has held it in 7 quarters since. 214 funds tracked by Wall St. Rank hold NARI as of Q1 2022.

  • Parametric Portfolio Associates held 47,691 shares of Inari Medical, Inc. Common Stock worth $4.32M as of Q1 2022.
  • Parametric Portfolio Associates bought 11,877 Inari Medical, Inc. Common Stock shares in Q1 2022, an estimated $972K.
  • Inari Medical, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1953 holding.
  • Parametric Portfolio Associates first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and has held it in 7 quarters since.
  • 214 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.